معرفی
Monty Krieger is the Whitehead Professor of Molecular Genetics at the Massachusetts Institute of Technology (MIT), affiliated with the Koch Biology Building. His research focuses on cell surface receptors, cholesterol metabolism, and their roles in physiology and diseases like atherosclerosis and infertility. He holds a PhD from the California Institute of Technology (1976) and a BS in Chemistry from Tulane University (1971).
Key research interests include the High Density Lipoprotein (HDL) receptor SR-BI, lipid transport mechanisms, and cardiovascular disease pathogenesis. His lab employs genetic, biochemical, and cellular approaches to study receptor structure-function relationships.
Notable awards include membership in the National Academy of Sciences (2009), the Tulane Outstanding Alumnus Award (2010), and the Margaret MacVicar Faculty Fellowship (1993–2003). Recent work involves developing mouse models for coronary artery disease and testing therapeutic strategies targeting cholesterol metabolism.
Publications span from foundational SR-BI discoveries (1996) to current studies on nanoparticle-based therapies (2024). Collaborations include teams at MIT, Tulane, and institutions globally, addressing clinical and mechanistic questions in lipid biology.
